You have read all your free articles, to continue reading subscribe to read the rest of this content.
Onxeo has turned to the public markets for cash to fuel its research and development ambitions, starting a rights issue in a bid to raise up to €41.6 million ($52.2 million). The Franco-Danish biotech plans to use the cash to expand a Phase III study of its liver cancer drug…
AstraZeneca and Evotec have launched a research collaboration focused on developing new drugs for kidney disease, the second partnership involving entities of the pharma giant and the German drug discovery alliance and development partnership company. The value of the collaboration was not disclosedAlready a subscriber Login You have read all…
Shionogi Co has selected Denmark as one of the countries in their Shionogi Science Program 2013. Shionogi Science Program invites researchers from selected countries outside Japan into joint studies. The aim is to invite novel, innovative and world-class ideas from researchers to create new pharmaceAlready a subscriber Login You have…
Johnson & Johnson’s Janssen Pharmaceutical Companies plan to invest $10 million in a new UK government-led global dementia discovery fund for research to find ways to prevent and treat dementia and Alzheimer's disease. The investment will come through its affiliate venture arm, Johnson & JAlready a subscriber Login You have…
